Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Mech Ageing Dev ; 126(5): 568-79, 2005 May.
Article in English | MEDLINE | ID: mdl-15811426

ABSTRACT

Calorie restriction (CR) reduces morbidity and mortality in a wide range of organisms, possibly through the stress response machinery. We analyzed the acute phase response of CR rats to lipopolysaccharide (LPS)-induced inflammatory challenge. Six-month-old male F344 rats, fed ad libitum (AL) or a 30% calorie-restricted diet from 6 weeks of age, received an intravenous LPS injection and were then sacrificed between 0 and 8 h. CR attenuated liver injury without reduction in the plasma concentrations of proinflammatory cytokines or nitric oxide (NO). Western blotting analysis of liver tissue demonstrated that CR did not affect the degradation of cytoplasmic I-kappaB and subsequent nuclear translocation of NF-kappaB, a key transcription factor after inflammatory challenge. We also analyzed the liver gene expression profiles at 0, 1 and 4 h with DNA arrays and cluster analysis. Compared with the AL group, CR upregulated the expression of several genes for inflammatory mediators or their related molecules at 0 h, but not at 1 or 4 h. CR downregulated genes for energy or xenobiotic metabolism and stress response proteins at 0 h. At 1 h, the relatively downregulated genes by CR were those for proteases and the ubiquitin-proteasome pathway. The present results suggest that CR attenuates liver injury without suppression of the proinflammatory response, and that the protective effect emerges from constitutively, rather than inductively, expressed gene products.


Subject(s)
Caloric Restriction , Inflammation/chemically induced , Inflammation/complications , Lipopolysaccharides , Stress, Physiological/etiology , Acute Disease , Alanine Transaminase/blood , Animals , Cell Nucleus/metabolism , Cytokines/blood , Cytoplasm/metabolism , Gene Expression , Gene Expression Profiling , I-kappa B Proteins/metabolism , Liver/metabolism , Male , Multigene Family , NF-kappa B/metabolism , Nitric Oxide/blood , Oligonucleotide Array Sequence Analysis , Rats , Rats, Inbred F344
2.
J Neuroimmunol ; 150(1-2): 80-7, 2004 May.
Article in English | MEDLINE | ID: mdl-15081251

ABSTRACT

We investigated immune property of a myoid cell line, established from Fisher rat thymus. Immunization of syngeneic rats with the myoid cells induced anti-rat acetylcholine receptor (AChR). Implantation of them into the thymus failed to induce typical thymic pathology of human myasthenia gravis (MG) or anti-AChR responses. We also demonstrated that the myoid cells were able to present exogenous antigens to T cells and induce antigen-specific T cell proliferation. These results suggest that myoid cells have the potential antigenicity to induce anti-AChR and the functions of antigen-presenting cells, but their expansion in the thymus may not directly cause MG.


Subject(s)
Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , Autoantigens/administration & dosage , Muscle, Skeletal/immunology , Myasthenia Gravis, Autoimmune, Experimental/immunology , Thymus Gland/immunology , Animals , Antigen Presentation , Autoantibodies/biosynthesis , Autoantigens/immunology , Autoantigens/metabolism , Cell Differentiation/immunology , Cell Line , Epitopes, T-Lymphocyte/immunology , Female , Humans , Injections, Intralymphatic , Injections, Subcutaneous , Muscle, Skeletal/cytology , Muscle, Skeletal/transplantation , Rats , Rats, Inbred F344 , Receptors, Cholinergic/immunology , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , Thymus Gland/cytology , Thymus Gland/transplantation
3.
Exp Gerontol ; 39(2): 195-202, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15036412

ABSTRACT

Organ-specific endonuclease might play a role in the age-related increase in apoptosis in laboratory rodent tissues. In nuclear extracts from liver tissues of male F344 rats, the DNase activity gel system identified DNase gamma, Ca(2+)/Mg(2+)-dependent endonuclease. The enzyme activity, which was measured at 3, 6, 16, and 24 months (mo) of age, was significantly increased between 16 and 24mo in control rats fed ad libitum (AL). The expression level of DNase gamma-mRNA, estimated by a semi-quantitative reverse transcription-polymerase chain reaction method, was also increased at 24mo in group AL. The proportion of immunohistochemically DNase gamma-positive cells, most of which were light-microscopically confined to apoptotic cells, was also significantly increased between 16 and 24mo. Dietary restriction, a powerful anti-aging intervention, which was achieved by providing 70% of the mean food intake in group AL from 6 weeks of age, inhibited the age-related increase in the enzyme activity and the proportion of immunostained cells; for the mRNA level, statistical significance was not obtained. The present study suggests that DNase gamma is involved in an age-related increase in the apoptosis of rat liver, and that CR inhibits the increase as it minimized the age-related increase in the fraction of DNA-damaged hepatocytes susceptible to apoptosis.


Subject(s)
Aging/metabolism , Apoptosis/physiology , Endodeoxyribonucleases/metabolism , Food Deprivation/physiology , Liver/enzymology , Aging/genetics , Animals , Cell Nucleus/enzymology , Endodeoxyribonucleases/genetics , Gene Expression Regulation, Developmental , Liver/cytology , Male , RNA, Messenger/genetics , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction
4.
Dig Dis Sci ; 48(10): 1984-9, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14627345

ABSTRACT

The present study was undertaken to evaluate p53 gene mutation as a prognostic factor in patients with colorectal cancer. Nonisotopic RNase cleavage assay (NIRCA), recently used for detecting gene mutations, was employed to detect p53 gene mutations in this study. In 15 samples of colorectal tumors, NIRCA was confirmed to be simple, accurate, and thus useful for clinical use, compared with polymerase chain reaction single-strand conformational polymorphism (PCR-SSCP). In another group of 79 cases of colorectal cancer analyzed for p53 gene mutation by using NIRCA, mutations were detected in 58 of 79 (73.4%) cases. Multivariate Cox proportional-hazards analysis showed that p53 gene mutation was a significant prognostic factor in patients with colorectal cancer. Our results showed that NIRCA is a simple and sensitive method, and thus useful for genetic screening of colorectal cancer. Furthermore, our results showed that p53 gene mutation is an independent predictor of poor prognosis in colorectal cancers.


Subject(s)
Colorectal Neoplasms/genetics , Genes, p53 , Mutation , Ribonucleases/chemistry , Aged , Female , Genetic Techniques , Humans , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Prognosis , Proportional Hazards Models , Sensitivity and Specificity , Survival Analysis
5.
Hepatogastroenterology ; 50(53): 1678-80, 2003.
Article in English | MEDLINE | ID: mdl-14571815

ABSTRACT

A 56-year-old man with a history of alcohol abuse presented with exertional dyspnea. A chest radiography showed a massive right pleural effusion with sanguineous pleural fluid and an amylase level of 97,188 IU/L. Despite conservative treatment with no oral intake, total parenteral nutrition and repeated thoracentesis, the pleural effusion was persistent and intrathoracic infection was suspected. Surgical intervention was proposed and a preoperative endoscopic retrograde cholangiopancreatography revealed disruption of the mid pancreatic duct and a fistulous tract. A middle segment pancreatectomy was performed for removal of the disrupted portion of the main pancreatic duct and reconstruction of the distal pancreas was completed by end-to-side Rouxen-Y pancreatojejunostomy. The patient had a good postoperative course and was discharged on the 29th postoperative day. He has remained well during the 9 months of follow-up.


Subject(s)
Pancreatic Fistula/complications , Pleural Diseases/complications , Pleural Effusion/surgery , Respiratory Tract Fistula/complications , Humans , Male , Middle Aged , Pancreatectomy , Pancreatic Fistula/surgery , Pancreaticojejunostomy , Pleural Effusion/etiology
6.
Dig Dis Sci ; 48(8): 1517-22, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12924646

ABSTRACT

This study was designed to provide a histopathological analysis focusing on fibrosis (staging) and necroinflammatory reaction (grading, hepatitis activity index: HAI) in noncancerous liver tissue, and mitotic index (MI) in cancerous liver tissue to predict prognosis in 81 patients with chronic hepatitis or cirrhosis who underwent hepatectomy for hepatocellular carcinoma (HCC). The incidence of grade 2/3 and higher HAI was higher in patients with viral hepatitis C. The incidence of grade 2/3 was associated with vascular invasion of HCC, postoperative liver dysfunction, and cancer recurrence. Higher MI (> or = 5) was significantly associated with vascular invasion, poor histological differentiation, and recurrence rate (P < 0.05). Multivariate analysis showed that higher grade was the factor strongly associated with cancer recurrence (odds ratio: 10.621, P = 0.006). Higher MI correlated with overall patient survival (P < 0.05) by univariate analysis. Grading and MI are the useful prognostic markers for predicting tumor recurrence and patient survival.


Subject(s)
Carcinoma, Hepatocellular/pathology , Hepatectomy , Hepatitis B/pathology , Hepatitis C/pathology , Liver Cirrhosis/pathology , Liver Neoplasms/pathology , Liver/pathology , Mitotic Index , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/surgery , Chemoembolization, Therapeutic , Female , Fluorouracil/administration & dosage , Hepatitis B/mortality , Hepatitis B/surgery , Hepatitis C/mortality , Hepatitis C/surgery , Humans , Liver Cirrhosis/drug therapy , Liver Cirrhosis/mortality , Liver Cirrhosis/surgery , Liver Neoplasms/drug therapy , Liver Neoplasms/mortality , Liver Neoplasms/surgery , Male , Mathematical Computing , Middle Aged , Neoadjuvant Therapy , Neoplasm Staging , Prognosis , Risk , Survival Rate
7.
Jpn J Thorac Cardiovasc Surg ; 51(6): 217-24, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12831234

ABSTRACT

OBJECTIVES: Preoperative chemotherapy is frequently used for advanced lung cancer. As a valid alternative to pneumonectomy, bronchoplasty has the advantage of enabling lung parenchyma function to be preserved. The effects of antineoplastic agents on healing bronchial anastomosis remain unclear. We studied the effects of preoperative chemotherapy on wound healing in bronchial anastomoses and clarified causes of wound healing impairment in rats. METHODS: In experiment I, at 3 days before surgery, rats were injected with cyclophosphamide, doxorubicin, and vincristine (CAV group) or cisplatin and etoposide (PVP treated rats). In experiment II, at 48 hrs before surgery, rats were treated with rabbit antirat macrophage serum and antirat monocyte chemoattractant protein-1 antibody to inhibit macrophage infiltration. On days 3, 5, and 7 after bronchus anastomosis, wound healing was assessed by examining bursting strength and hydroxyproline tissue content. RESULTS: CAV-treated rats showed significant impaired wound healing, marked severe leucopenia, and reduced macrophage infiltration. The PVP group showed no significant changes. In experiment II, rats exhibited inhibited macrophage infiltration, which is associated with significantly impaired of wound healing. CONCLUSIONS: Our study suggests that induction chemotherapy, associated with leukopenia in the early phase of wound healing, increases the risk of bronchial anastomosis leakage. Postoperative macrophage depletion is one of the most important causes of impaired wound healing.


Subject(s)
Anastomosis, Surgical , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Bronchi/surgery , Cisplatin/pharmacology , Cyclophosphamide/pharmacology , Doxorubicin/pharmacology , Etoposide/pharmacology , Vincristine/pharmacology , Wound Healing/drug effects , Animals , Doxorubicin/analogs & derivatives , Male , Rats , Rats, Wistar
8.
Hepatogastroenterology ; 50(51): 696-9, 2003.
Article in English | MEDLINE | ID: mdl-12828063

ABSTRACT

BACKGROUND/AIMS: We hypothesize that a subset of node-negative colorectal cancer patients exists that is at high risk for recurrence after curative surgery. Preoperative serum levels of sialyl Lewisa (CA19-9), sialyl Lewisx (SLX), sialyl Tn (STN), and carcinoembryonic (CEA) antigens were analyzed for their value in predicting for such a group. METHODOLOGY: One-hundred-forty-five patients with node-negative, T1-4, M0 colorectal cancers were divided into groups of low or high serum antigen levels. Disease-free interval served as the endpoint in evaluating the prognostic strength of each variable. RESULTS: Twenty-seven patients (18.6%) were included in the high group for CA19-9 antigen, 11 (7.6%) for SLX, 13 (9.0%) for STN, and 51 (35.2%) for CEA. The median follow-up was 62.1 months. As compared to those with low levels, patients with elevated CA19-9 had a shorter disease-free interval (P = 0.0026). No significant difference in disease-free interval was noted between low and high groups of SLX, STN, and CEA antigens. Cox regression analysis identified elevated serum CA19-9 level as a predictor for decreased disease-free interval, independent of T-stage or tumor location. CONCLUSIONS: Elevated preoperative serum levels of CA19-9 may serve as a useful marker in identifying patients with node-negative colorectal cancers at high risk for recurrence after surgery.


Subject(s)
Adenocarcinoma/surgery , Biomarkers, Tumor/blood , CA-19-9 Antigen/blood , Colorectal Neoplasms/surgery , Neoplasm Recurrence, Local/diagnosis , Adenocarcinoma/blood , Adenocarcinoma/diagnosis , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/blood , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/pathology , Disease-Free Survival , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Recurrence, Local/blood , Neoplasm Staging , Predictive Value of Tests
9.
Hepatogastroenterology ; 50(51): 704-8, 2003.
Article in English | MEDLINE | ID: mdl-12828065

ABSTRACT

BACKGROUND/AIMS: Minimally invasive surgery, with its advantages of early return to normal activity and good cosmetic results, is an important goal in the treatment of patients with mucosal ulcerative colitis. The aim of this study was to compare outcomes utilizing a mini-laparotomy approach to total abdominal colectomy for mucosal ulcerative colitis with those of the conventional approach. METHODOLOGY: Eleven patients scheduled to undergo the first (total abdominal colectomy) of a 2 or 3-stage operation for mucosal ulcerative colitis via a mini-laparotomy between 1999 and 2001 were prospectively studied. The mini-laparotomy described here involves total abdominal colectomy performed through a skin incision shorter than 7 cm. Seven similar patients who underwent conventional laparotomy between 1995 and 1998 served as the control group. RESULTS: The mini-laparotomy approach was accomplished in 9 patients (81.8%). Patient characteristics between cases and controls were similar. Postoperative intervals until standing, walking, flatus, urinary catheter removal, and tolerance of solid diet were significantly shorter in the mini-laparotomy group (P = 0.031, P = 0.023, P = 0.0033, P = 0.0093, and P = 0.023, respectively). CONCLUSIONS: A mini-laparotomy approach to total abdominal colectomy appears feasible and safe in selected patient with mucosal ulcerative colitis and poses an attractive alternative to conventional laparotomy in patients similar to those presented here.


Subject(s)
Colectomy/instrumentation , Colitis, Ulcerative/surgery , Laparotomy/instrumentation , Minimally Invasive Surgical Procedures/instrumentation , Adult , Aged , Colonic Pouches , Feasibility Studies , Female , Humans , Ileostomy , Male , Middle Aged , Postoperative Complications/etiology , Prospective Studies , Surgical Instruments
10.
J Laparoendosc Adv Surg Tech A ; 13(2): 99-103, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12737723

ABSTRACT

BACKGROUND: This report describes an experience with gasless video transanal endoscopic microsurgery (VTEM) to excise rectal tumors previously incompletely removed with colonoscopic snare polypectomy. METHODS: Gasless VTEM involves a modification of transanal endoscopic microsurgery (TEM) that incorporates a standard laparoscopic video camera and requires no CO(2) insufflation system. Nineteen patients who had had a rectal tumor removed incompletely by colonoscopic polypectomy with a diathermy snare were enrolled in this prospective study. The patients included 14 men and 5 women whose median age was 63.5 (range, 49-83) years. The rectal tumors included 4 adenomas, 11 adenocarcinomas (Tis, 7; T1, 4), and 4 carcinoid tumors. The median distance from the tumor margin to the dentate line was 5.8 (range, 2.0-13.0) cm. RESULTS: All rectal lesions were successfully removed by gasless VTEM. No intraoperative complication occurred. The median operating time and blood loss were 40 (range, 15-145) minutes and 5 (range, 0-100) mL, respectively. The median maximal tumor diameter in 9 patients with residual tumors was 1.3 (range, 0.5-2.5) cm. There was no operative mortality. A postoperative complication (bleeding from a suture wound and transient incontinence) developed in 1 (5.3%) of the 19 patients. The median postoperative hospital stay was 5 (range, 2-10) days. Postoperative histology revealed a residual tumor in 10 (52.9%) of the 19 specimens. Complete excision of all tumors was confirmed histologically. During a median follow-up period of 59.5 (range, 12.3-94.9) months, no tumor recurred. CONCLUSIONS: Gasless VTEM is useful and minimally invasive for the local removal of rectal tumors incompletely resected by colonoscopic snare polypectomy.


Subject(s)
Adenocarcinoma/surgery , Adenoma/surgery , Endoscopy, Gastrointestinal/methods , Rectal Neoplasms/surgery , Video-Assisted Surgery/methods , Aged , Aged, 80 and over , Colonoscopy , Female , Humans , Male , Middle Aged , Prospective Studies , Reoperation , Treatment Outcome
11.
Tohoku J Exp Med ; 199(1): 1-12, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12688555

ABSTRACT

The effect of preoperative irradiation and antineoplastic agents on healing at the site of bronchial anastomosis was investigated using rats. The bursting pressure in irradiation group and combined irradiation and chemotherapy group was significantly lower than in control and chemotherapy group at day 5 after operation. There was no significant difference in bursting pressure in all groups at day 7. The histologic finding of the anastomosis with H & E stain showed that submucosal connective tissue had not regenerated, and defects were seen in the submucosal tissue in irradiation and combined therapy group at day 3 and day 5. But, the connective tissue had matured in irradiation group at day 7 compared with control group. In conclusion, this study demonstrated that the healing of bronchial anastomosis was markedly delayed in early postoperative days in the rats receiving irradiation and combined therapy.


Subject(s)
Anastomosis, Surgical , Antineoplastic Agents/pharmacology , Bronchi/drug effects , Bronchi/radiation effects , Wound Healing/drug effects , Wound Healing/radiation effects , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Body Weight/drug effects , Body Weight/physiology , Body Weight/radiation effects , Bronchi/pathology , Cisplatin/pharmacology , Etoposide/pharmacology , Hydroxyproline/metabolism , Leukocyte Count , Male , Pressure , Radiation-Sensitizing Agents/pharmacology , Rats , Rats, Wistar
12.
J Heart Lung Transplant ; 22(4): 452-9, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12681423

ABSTRACT

BACKGROUND: Cytomegalovirus (CMV) diseases commonly occur in allograft recipients in the early post-transplant period. However, factors responsible for the high incidence of CMV diseases during this period are not yet fully defined. METHODS: Wistar-Furth (WF; RT-1(u)) rats were inoculated with 10(4) plaque-forming units (PFU) of rat CMV (RCMV) intraperitoneally, and then transplanted with allogeneic lungs from Dark Agouti (DA; RT-1avl) rats or stimulated with 10(7) mitomycin C-treated spleen cells from DA rats by daily sub-cutaneous injections for 2 weeks. No immunosuppressive agent was used. Naive WF rats and WF rats grafted with syngeneic lungs or cells were used as controls. The level of RCMV replication in rats was assessed by infectious virus titers in tissues. RESULTS: The virus titers in salivary glands of allogeneic and syngeneic lung graft recipients were significantly higher than in naive WF rats. The level of RCMV replication in rats stimulated with allogeneic spleen cells was significantly higher than in the syngeneic recipient rats: virus titers in the salivary gland of allogeneic and syngeneic recipients reached 4.61 +/- 0.33 and 4.00 +/- 0.37 log(10) PFU/g tissue, respectively, at 14 days post-infection (p = 0.015). The augmented viral replication in allogeneic recipients was confirmed by an increase in the number of RCMV antigen-positive macrophages present in tissue sections of the salivary gland. CONCLUSIONS: Acute lung allograft rejection and allogeneic spleen cell stimulation enhance CMV replication in the salivary gland of rats. Various responses to allogeneic antigens occurring in the process of acute allograft rejection could be risk factors for post-transplant CMV replication and infection.


Subject(s)
Cytomegalovirus Infections/etiology , Cytomegalovirus Infections/physiopathology , Cytomegalovirus/physiology , Graft Rejection/complications , Graft Rejection/physiopathology , Lung Transplantation/adverse effects , Spleen/physiopathology , Transplantation, Homologous/adverse effects , Virus Replication/physiology , Alkylating Agents/adverse effects , Animals , Cytomegalovirus/drug effects , Disease Models, Animal , Male , Mitomycin/adverse effects , Rats , Rats, Inbred WF , Spleen/drug effects , Stimulation, Chemical , Time Factors , Virus Replication/drug effects
13.
World J Surg ; 27(2): 197-202, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12616436

ABSTRACT

This study compares surgical outcomes for local resection of rectal tumors by two approaches: (1) gasless, video-endoscopic transanal-rectal tumor excision (gasless VTEM); and (2) a conventional posterior approach. Gasless VTEM involves a modification of transanal endoscopic microsurgery (TEM) that incorporates a standard laparoscopic video camera without a CO(2) insufflation system. A series of 42 patients with 45 rectal tumors (9 adenomas, 36 adenocarcinomas) who underwent gasless VTEM between 1993 and 2000 were studied prospectively. The control group consisted of 26 similar patients who underwent conventional surgery (transsacral or transsphincteric approach) between 1985 and 1993. Age, gender ratio, tumor localization, maximum tumor diameter, and histology for the cases and the controls were similar, whereas operating time and blood loss were significantly greater in the control group (p < 0.001 and p < 0.001, respectively). The postoperative intervals until able to walk, urinary catheter removal, solid food intake, and discharge from hospital were significantly shorter in the gasless VTEM group (p < 0.001, p = 0.002, p < 0.001, and p < 0.001, respectively); analgesic requirements were significantly less (p < 0.001). There was no operative mortality in either group. Postoperative complications developed significantly less frequently in the gasless VTEM group than in the control group (7.1% vs. 38.5%; p = 0.003). During the median follow-up length of 73.3 months, no patient developed tumor recurrence in the gasless VTEM group, whereas one patient did in the control group. In conclusion, gasless VTEM is less invasive and allows shorter hospitalizations and reduced complications than the conventional posterior approach, thereby providing an attractive alternative for selected patients.


Subject(s)
Adenocarcinoma/surgery , Adenoma/surgery , Endoscopy, Gastrointestinal/methods , Rectal Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome
14.
Ann Surg Oncol ; 10(2): 163-70, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12620912

ABSTRACT

BACKGROUND: The aim of this study was to clarify the prognostic value of distal intramural spread of tumor for survival and recurrence in patients with rectal cancer. METHODS: Microscopic distal intramural spread was examined in 134 consecutive specimens of resected rectal cancer. Correlations among distal intramural spread, established clinicopathologic factors, and patients' prognoses were examined by univariate and multivariate analyses. American Joint Committee on Cancer classification and stage groupings were used for tumor assessment. RESULTS: Thirty-three patients (24.6%) had distal intramural spread. Multivariate logistical regression analysis revealed that T3/T4 and M1 were independent predictive variables for the presence of distal intramural spread. Patients with distal intramural spread had a shorter disease-specific or disease-free survival time after curative surgery than those without distal intramural spread (P =.0003 and P =.0006, respectively). Most patients with distal intramural spread developed distant recurrence. Cox's regression with multiple covariates showed that distal intramural spread is an independent factor in predicting distant recurrence and worse outcomes after curative surgery in patients with rectal cancer. CONCLUSIONS: Distal intramural spread is an independent risk factor for distant metastasis and poor prognosis in patients with rectal cancer.


Subject(s)
Adenocarcinoma/pathology , Rectal Neoplasms/pathology , Adenocarcinoma/drug therapy , Adenocarcinoma/surgery , Adult , Antimetabolites, Antineoplastic/therapeutic use , Combined Modality Therapy , Female , Fluorouracil/therapeutic use , Humans , Logistic Models , Lymphatic Metastasis , Male , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Staging , Prognosis , Proportional Hazards Models , Rectal Neoplasms/drug therapy , Rectal Neoplasms/surgery , Retrospective Studies , Risk Factors
15.
Surg Today ; 33(1): 1-6, 2003.
Article in English | MEDLINE | ID: mdl-12560899

ABSTRACT

PURPOSE: We investigated the postoperative complications that developed in patients who underwent surgery after induction chemotherapy (IC) for primary lung cancer. METHODS: Twenty-seven patients underwent surgery after receiving IC; for advanced non-small cell lung cancer in 16, and for small cell lung cancer in 11. All patients were given the platinum-based chemotherapy regimen. RESULTS: Lobectomies were performed for 18 patients, bilobectomies for 4, pneumonectomies for 2, and partial resections or segmentectomies for 3. There were two postoperative deaths; one caused by adult respiratory distress syndrome (ARDS) and one caused by respiratory failure, resulting in a mortality rate of 7.4%. The postoperative complications included sputum retention in six patients, ARDS in two, anastomotic dehiscence after bronchoplasty in one, and pneumonia in one, resulting in 44.4% morbidity. The morbidity of patients who had received IC (IC group) was higher than that of a comparative group of 560 who underwent lung resection without IC during the same period (non-IC group), but the difference was not significant (44.4% vs 22.6%; P = 0.16). Both ARDS and bronchial insufficiency occurred more frequently in the IC group than in the non-IC group, but the differences were not significant ( P = 0.25). CONCLUSIONS: These findings indicate the feasibility of treating primary lung cancer with IC followed by surgery as long as a cautious operative procedure is used and careful postoperative management is given, paying particular attention to the risk of ARDS and bronchial complications.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/surgery , Carcinoma, Small Cell/drug therapy , Carcinoma, Small Cell/surgery , Lung Neoplasms/drug therapy , Lung Neoplasms/surgery , Pneumonectomy/adverse effects , Postoperative Complications , Adult , Aged , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Small Cell/pathology , Cisplatin/administration & dosage , Combined Modality Therapy , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Retrospective Studies , Risk Assessment
16.
Chest ; 123(1): 293-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12527636

ABSTRACT

BACKGROUND: Several recent studies discuss bronchoscopic techniques for treating endobronchial lipoma, an extremely rare benign tumor. OBJECTIVES: To describe the epidemiology of endobronchial lipoma and to propose appropriate therapeutic policies for treating this tumor. METHODS: We reviewed 64 cases of endobronchial lipoma: 33 cases previously reported in 30 different articles, and 31 case reports presented at thoracic meetings in Japan. RESULTS: Of the 64 patients included in this study (50 male and 14 female; mean age, 60 years), 40 patients had endobronchial lipoma in the right lung and 23 patients had it in the left lung. The overwhelming majority of the tumors (n = 61) were found in the first three subdivisions of the tracheobronchial tree. Forty-eight patients (75%) were symptomatic, and their symptoms included cough, sputum, hemoptysis, elevated temperature, and dyspnea. Additionally, abnormal radiographic findings were reported for 51 patients (80%): 18 patients had atelectasis, 14 patients had infiltration or consolidation, 6 patients showed volume loss of the lung, and mass shadow was identified in 9 patients, and another abnormality including pleural effusion was found in 4 patients. Forty patients underwent surgical resection: 4 pneumonectomies, 24 lobectomies, 8 bilobectomies, and 4 resections by bronchotomy. Bronchoscopic resection was carried out in 17 cases: 7 cases by Nd-YAG laser, 5 cases by electrosurgical snaring forceps, and another 5 cases with a combined therapy using both procedures. CONCLUSIONS: Bronchoscopic resection should be considered as the first choice of treatment for endobronchial lipoma; however, surgical therapy is indicated for patients who show the possibility of a complicated malignant tumor, who have destructive peripheral lung disease, who have extrabronchial growth, or who may have technical difficulties during the bronchoscopic procedure.


Subject(s)
Bronchial Neoplasms , Lipoma , Bronchial Neoplasms/diagnosis , Bronchial Neoplasms/epidemiology , Bronchial Neoplasms/etiology , Bronchial Neoplasms/therapy , Female , Humans , Japan , Lipoma/diagnosis , Lipoma/epidemiology , Lipoma/etiology , Lipoma/therapy , Middle Aged
17.
J Hepatobiliary Pancreat Surg ; 9(4): 485-9, 2002.
Article in English | MEDLINE | ID: mdl-12483271

ABSTRACT

PURPOSE/BACKGROUND: Increased numbers of argyrophilic nucleolar organizer region (AgNOR) dots reflect higher proliferating activity of malignant cells. METHODS: To determine whether AgNOR staining is suitable for cytology of bile in biliary diseases as an ancillary diagnostic method, we examined the mean number of AgNOR dots (MNA) in cells of both bile smear and tissue sections in 14 benign biliary diseases and 25 malignancies of the biliary tract. The malignant diseases consisted of 11 gallbladder cancers, 10 bile duct cancers, and 4 ampulla cancers in patients who underwent surgical resection. Results of AgNOR staining were available in 15 min, and the MNA in the nucleus was counted in 50 cells/specimen. RESULTS: The MNAs in malignant cells in bile smear (9.6 +/- 3.8) and tissue sections (9.2 +/- 3.5) were significantly higher than those in the corresponding cells in benign biliary diseases (4.1 +/- 1.0 and 2.9 +/- 0.8, respectively; P< 0.01). The MNA of bile smear for both benign and malignant cells correlated significantly with that of tissue sections ( r= 0.915; P< 0.0001). When the cutoff value of MNA for bile smear was set at 7.0, benign diseases could be discriminated from malignancy, and the MNA of 20 (80%) malignant specimens was higher than this value. CONCLUSIONS: Our results suggest that the AgNOR dot count of cells in bile smears would be a useful diagnostic tool, in combination with conventional cytological diagnosis, before and during surgery.


Subject(s)
Biliary Tract Neoplasms/metabolism , Nuclear Proteins/metabolism , Aged , Antigens, Nuclear , Bile/cytology , Bile/metabolism , Female , Gallbladder Neoplasms/metabolism , Histocytochemistry , Humans , Male , Middle Aged
18.
J Gastroenterol ; 37(10): 791-7, 2002.
Article in English | MEDLINE | ID: mdl-12424562

ABSTRACT

BACKGROUND: Macroscopic classification of metastatic liver tumors has been recommended to predict patient prognosis. METHODS: We examined the morphological analysis of metastatic colorectal cancer in 64 patients who underwent hepatic resection and the relationship with clinicopathologic factors. To identify the irregularity of the tumor, we calculated three formulas: (1) actual area of representative cut surface of tumor/circular length of tumor margin, (2) actual area of representative cut surface of tumor/elliptic area, defined by the major and minor axes, and (3) deviation of radius of marginal curvature. RESULTS: Following Yasui's macroscopic classification, the values of formulas (1) and (2) in confluent nodules were significantly lower than those in simple nodules ( P < 0.05), while the value of formula (3) in confluent nodules was significantly greater than that in simple nodules ( P< 0.05). Only a lower value of formula (1) (less than 0.19) was significantly associated with postoperative recurrence ( P< 0.05) and a lower value tended to be associated with a shorter disease-free survival after hepatectomy, but not significantly ( P= 0.09). However, most values were not associated with any clinicopathologic factors or postoperative survival. CONCLUSIONS: We conclude that differences in the morphological irregularity of liver tumors in metastatic colorectal cancer do not have clinical significance.


Subject(s)
Colorectal Neoplasms/pathology , Liver Neoplasms/secondary , Adult , Aged , Colorectal Neoplasms/mortality , Disease-Free Survival , Female , Hepatectomy , Humans , Liver Neoplasms/pathology , Liver Neoplasms/surgery , Male , Middle Aged , Multivariate Analysis , Survival Rate
19.
Gan To Kagaku Ryoho ; 29(8): 1469-73, 2002 Aug.
Article in Japanese | MEDLINE | ID: mdl-12214480

ABSTRACT

The first patient was a 51-year-old male who had 5-fluorouracil-resistant recurrent rectal cancer with multiple liver metastases. He was given our new combination chemotherapy consisting of hepatic arterial injection of CPT-11 (20 mg/body) on day 1 and day 2 and oral administration of UFT (300 mg/day) on days 3 to 6 of a 7 day cycle starting in January 2001. Six weeks after the beginning of chemotherapy, the liver metastatic lesions were reduced. He is now living with outpatient treatment. The second patient was a 76-year-old male who had initial recurrent rectal cancer with multiple liver metastases. Thirty-two weeks after the same chemotherapy, the metastatic lesions had completely disappeared. Twelve months have passed since this chemotherapy, and we have not found any recurrent tumor. While significant antitumor effects were observed, there were few adverse events in either patient. These results suggest that combined chemotherapy of CPT-11 by hepatic arterial injection and oral administration of UFT is an effective treatment for liver metastases of rectal cancer.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/secondary , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Rectal Neoplasms/drug therapy , Administration, Oral , Aged , Camptothecin/administration & dosage , Camptothecin/analogs & derivatives , Drug Administration Schedule , Drug Combinations , Hepatic Artery , Humans , Injections, Intra-Arterial , Irinotecan , Male , Middle Aged , Rectal Neoplasms/pathology , Tegafur/administration & dosage , Uracil/administration & dosage
20.
World J Surg ; 26(6): 721-5, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12053226

ABSTRACT

The feasibility and safety of a minilaparotomy approach to terminal ileal Crohn's disease have not been fully elucidated. The purpose of this study was to compare early outcomes utilizing this technique as an alternative to conventional approaches. Nine patients with terminal ileal Crohn's disease (but no complicating enteric fistulas) who underwent minilaparotomy between January 1998 and September 2000 were studied prospectively. The minilaparotomy approach entails a complete surgical procedure performed through a skin incision of less than 7 cm. Ten similar patients who underwent conventional laparotomy between January 1995 and December 1997 served as the control group. Age, gender, body weight, height, body mass index, number of prior laparotomies, operating times, operative blood loss, and types of operative procedure were similar for cases and controls. The length of the laparotomy incision in the minilaparotomy approach group was significantly shorter than that in the conventional approach group (median length 6.0 vs. 16.5 cm; p <0.05). Postoperative intervals until initial standing and walking were significantly shorter for minilaparotomy patients than conventional surgery patients (p <0.05 and p <0.05, respectively), whereas postoperative intervals until passing flatus, urinary catheter removal, and tolerance of liquids and solids did not differ for the two groups, nor did the analgesic requirement or postoperative hospital stay. Postoperative complications developed in two conventional-group patients; none was noted with the minilaparotomy approach. Our data suggest that the minilaparotomy approach to terminal ileal Crohn's disease without an enteric fistula is feasible, safe, and less invasive than the conventional approach.


Subject(s)
Crohn Disease/surgery , Laparotomy/methods , Minimally Invasive Surgical Procedures/methods , Adult , Crohn Disease/diagnosis , Feasibility Studies , Female , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...